lobbying_activities: 1261074

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1261074	d15a28bd-b85a-4687-9020-4ab15ad7971f	Q2	TURNER & GOSS LLP	316310	CYSTIC FIBROSIS FOUNDATION	2012	second_quarter	MED	Food and Drug Administration Safety and Innovation Act, including provisions of the Expanding and Promoting Exertise in Review of Rare Treatments Act of 2012 (S. 2281/HR 4156) as incorporated in the Act	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2012-07-12T12:35:32.277000-04:00